Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lawson ARJ"'
Autor:
Hurst, CD, Cheng, G, Platt, FM, Marzouka, N-A-DS, Eriksson, P, Black, EVI, Alder, O, Lawson, ARJ, Lindskrog, SV, Burns, JE, Jain, S, Roulson, J-A, Brown, JC, Koster, J, Robertson, AG, Martincorena, I, Dyrskjøt, L, Höglund, M, Knowles, MA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::0b2d90122beeb8bbd96afad11c423b34
Autor:
Ijaz J; Wellcome Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: jijaz@altoslabs.com., Harry E; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Raine K; Wellcome Sanger Institute, Hinxton CB10 1SA, UK; Health Innovation East, Unit C, Magog Court, Shelford Bottom, Cambridge CB22 3AD, UK., Menzies A; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Beal K; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Quail MA; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Zumalave S; Mobile Genomes and Disease, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain., Jung H; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Coorens THH; Wellcome Sanger Institute, Hinxton CB10 1SA, UK; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lawson ARJ; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Leongamornlert D; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Francies HE; Wellcome Sanger Institute, Hinxton CB10 1SA, UK; GSK, Gunnels Wood Road, Stevenage SG1 2NY, UK., Garnett MJ; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Ning Z; Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Campbell PJ; Wellcome Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: pc8@sanger.ac.uk.
Publikováno v:
Cell genomics [Cell Genom] 2024 Feb 14; Vol. 4 (2), pp. 100484. Date of Electronic Publication: 2024 Jan 16.
Autor:
Olafsson S; Wellcome Sanger Institute, Hinxton, UK., Rodriguez E; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany., Lawson ARJ; Wellcome Sanger Institute, Hinxton, UK., Abascal F; Wellcome Sanger Institute, Hinxton, UK., Huber AR; Institute for Research in Biomedicine, Barcelona, Spain., Suembuel M; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany., Jones PH; Wellcome Sanger Institute, Hinxton, UK., Gerdes S; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany., Martincorena I; Wellcome Sanger Institute, Hinxton, UK., Weidinger S; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany., Campbell PJ; Wellcome Sanger Institute, Hinxton, UK., Anderson CA; Wellcome Sanger Institute, Hinxton, UK. carl.anderson@sanger.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2023 Nov; Vol. 55 (11), pp. 1892-1900. Date of Electronic Publication: 2023 Oct 26.
Autor:
Gong S; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK; Centre for Trophoblast Research (CTR), Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Gaccioli F; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK; Centre for Trophoblast Research (CTR), Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Aye ILMH; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK; Centre for Trophoblast Research (CTR), Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Avellino G; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK; Centre for Trophoblast Research (CTR), Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Cook E; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Lawson ARJ; Wellcome Trust Sanger Institute, Hinxton, UK., Harvey LMR; Wellcome Trust Sanger Institute, Hinxton, UK., Smith GCS; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK; Centre for Trophoblast Research (CTR), Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Charnock-Jones DS; Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK; Centre for Trophoblast Research (CTR), Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. Electronic address: dscj1@cam.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2023 Jul 25; Vol. 42 (7), pp. 112800. Date of Electronic Publication: 2023 Jul 14.
Autor:
Ellis P; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK.; Inivata Limited, The Glenn Berge Building, Babraham Research Campus, Babraham, UK., Moore L; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Sanders MA; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK.; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Butler TM; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Brunner SF; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Lee-Six H; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Osborne R; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK.; Inivata Limited, The Glenn Berge Building, Babraham Research Campus, Babraham, UK., Farr B; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Coorens THH; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Lawson ARJ; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Cagan A; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Stratton MR; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Martincorena I; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Campbell PJ; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK. pc8@sanger.ac.uk.
Publikováno v:
Nature protocols [Nat Protoc] 2023 Jun; Vol. 18 (6), pp. 1979.
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer.
Autor:
Li R; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Ferdinand JR; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK., Loudon KW; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Bowyer GS; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK., Laidlaw S; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Muyas F; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Mamanova L; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Neves JB; UCL Division of Surgery and Interventional Science, Royal Free Hospital, London NW3 2PS, UK; Specialist Centre for Kidney Cancer, Royal Free Hospital, London NW3 2PS, UK., Bolt L; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Fasouli ES; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Lawson ARJ; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Young MD; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Hooks Y; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Oliver TRW; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Butler TM; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Armitage JN; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Aho T; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Riddick ACP; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Gnanapragasam V; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK., Welsh SJ; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Meyer KB; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Warren AY; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Tran MGB; UCL Division of Surgery and Interventional Science, Royal Free Hospital, London NW3 2PS, UK; Specialist Centre for Kidney Cancer, Royal Free Hospital, London NW3 2PS, UK., Stewart GD; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK., Cortés-Ciriano I; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Behjati S; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Clatworthy MR; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Campbell PJ; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Teichmann SA; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Department of Physics, Cavendish Laboratory, JJ Thomson Avenue, Cambridge CB3 0HE, UK. Electronic address: st9@sanger.ac.uk., Mitchell TJ; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: tjm@sanger.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Dec 12; Vol. 40 (12), pp. 1583-1599.e10. Date of Electronic Publication: 2022 Nov 23.
Autor:
Cagan A; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK. ac36@sanger.ac.uk., Baez-Ortega A; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Brzozowska N; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Abascal F; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Coorens THH; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Sanders MA; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Lawson ARJ; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Harvey LMR; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Bhosle S; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Jones D; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Alcantara RE; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Butler TM; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Hooks Y; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Roberts K; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Anderson E; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Lunn S; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Flach E; Wildlife Health Services, Zoological Society of London, London, UK., Spiro S; Wildlife Health Services, Zoological Society of London, London, UK., Januszczak I; Wildlife Health Services, Zoological Society of London, London, UK.; The Natural History Museum, London, UK., Wrigglesworth E; Wildlife Health Services, Zoological Society of London, London, UK., Jenkins H; Wildlife Health Services, Zoological Society of London, London, UK., Dallas T; Wildlife Health Services, Zoological Society of London, London, UK., Masters N; Wildlife Health Services, Zoological Society of London, London, UK., Perkins MW; Institute of Zoology, Zoological Society of London, London, UK., Deaville R; Institute of Zoology, Zoological Society of London, London, UK., Druce M; Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH (HI-STEM), Heidelberg, Germany., Bogeska R; Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH (HI-STEM), Heidelberg, Germany., Milsom MD; Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH (HI-STEM), Heidelberg, Germany., Neumann B; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Gorman F; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK., Constantino-Casas F; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK., Peachey L; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.; Bristol Veterinary School, Faculty of Health Sciences, University of Bristol, Langford, UK., Bochynska D; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.; Department of Pathology, Faculty of Veterinary Medicine, Universitatea de Stiinte Agricole si Medicina Veterinara, Cluj-Napoca, Romania., Smith ESJ; Department of Pharmacology, University of Cambridge, Cambridge, UK., Gerstung M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK., Campbell PJ; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Murchison EP; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK., Stratton MR; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK., Martincorena I; Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, UK. im3@sanger.ac.uk.
Publikováno v:
Nature [Nature] 2022 Apr; Vol. 604 (7906), pp. 517-524. Date of Electronic Publication: 2022 Apr 13.
Autor:
Hurst CD; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Cheng G; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Platt FM; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Castro MAA; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Curitiba, Brazil., Marzouka NS; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Black EVI; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Alder O; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Lawson ARJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Burns JE; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Jain S; Pyrah Department of Urology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Roulson JA; Department of Histopathology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Brown JC; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK., Koster J; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands., Robertson AG; Canada's Michael Smith Genome Sciences Center, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Martincorena I; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Knowles MA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2021 Dec 21; Vol. 2 (12), pp. 100472. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
Autor:
Robinson PS; Wellcome Sanger Institute, Hinxton, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK., Coorens THH; Wellcome Sanger Institute, Hinxton, UK., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Mitchell E; Wellcome Sanger Institute, Hinxton, UK., Abascal F; Wellcome Sanger Institute, Hinxton, UK., Olafsson S; Wellcome Sanger Institute, Hinxton, UK., Lee BCH; Wellcome Sanger Institute, Hinxton, UK.; Hereditary Gastrointestinal Cancer Genetic Diagnosis Laboratory, Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong., Lawson ARJ; Wellcome Sanger Institute, Hinxton, UK., Lee-Six H; Wellcome Sanger Institute, Hinxton, UK., Moore L; Wellcome Sanger Institute, Hinxton, UK., Sanders MA; Wellcome Sanger Institute, Hinxton, UK.; Department of Haematology, Erasmus University Medical Centre, Rotterdam, the Netherlands., Hewinson J; Wellcome Sanger Institute, Hinxton, UK., Martin L; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Pinna CMA; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Galavotti S; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Rahbari R; Wellcome Sanger Institute, Hinxton, UK., Campbell PJ; Wellcome Sanger Institute, Hinxton, UK., Martincorena I; Wellcome Sanger Institute, Hinxton, UK., Tomlinson I; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK. Ian.Tomlinson@igmm.ed.ac.uk., Stratton MR; Wellcome Sanger Institute, Hinxton, UK. mrs@sanger.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2021 Oct; Vol. 53 (10), pp. 1434-1442. Date of Electronic Publication: 2021 Sep 30.
Autor:
Coorens THH; Wellcome Sanger Institute, Hinxton, UK., Moore L; Wellcome Sanger Institute, Hinxton, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Robinson PS; Wellcome Sanger Institute, Hinxton, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK., Sanghvi R; Wellcome Sanger Institute, Hinxton, UK., Christopher J; Wellcome Sanger Institute, Hinxton, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Hewinson J; Wellcome Sanger Institute, Hinxton, UK., Przybilla MJ; Wellcome Sanger Institute, Hinxton, UK., Lawson ARJ; Wellcome Sanger Institute, Hinxton, UK., Spencer Chapman M; Wellcome Sanger Institute, Hinxton, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Cagan A; Wellcome Sanger Institute, Hinxton, UK., Oliver TRW; Wellcome Sanger Institute, Hinxton, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Neville MDC; Wellcome Sanger Institute, Hinxton, UK., Hooks Y; Wellcome Sanger Institute, Hinxton, UK., Noorani A; Wellcome Sanger Institute, Hinxton, UK., Mitchell TJ; Wellcome Sanger Institute, Hinxton, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Surgery, University of Cambridge, Cambridge, UK., Fitzgerald RC; MRC Cancer Unit, University of Cambridge, Biomedical Campus, Cambridge, UK., Campbell PJ; Wellcome Sanger Institute, Hinxton, UK., Martincorena I; Wellcome Sanger Institute, Hinxton, UK., Rahbari R; Wellcome Sanger Institute, Hinxton, UK., Stratton MR; Wellcome Sanger Institute, Hinxton, UK. mrs@sanger.ac.uk.
Publikováno v:
Nature [Nature] 2021 Sep; Vol. 597 (7876), pp. 387-392. Date of Electronic Publication: 2021 Aug 25.